Role of Vonoprazan-Amoxicillin Dual Therapy in Pediatric Refractory Helicobacter Pylori Infection in Children: Early Experience From A Single-Center Case Series
This small case series presents real-world experience on the efficacy of dual therapy with vonoprazan and amoxicillin in pediatric patients with refractory, antimicrobial-resistant <i>Helicobacter pylori</i> infection and highlights the role of adequate acid suppression in treatment success. Dual therapy with vonoprazan and amoxicillin was well tolerated and resulted in successful eradication in all patients.
Authors
- Silvana Bonilla (ORCID: https://orcid.org/0000-0001-6665-825X)
- Maria Camila Cardenas Fernandez
- Kim Ruiz Arellanos
Institutions
- Boston Children's Hospital (US)
- Harvard University (US)
Publication Details
- Journal
- ACG Case Reports Journal
- Published
- 2025-10-01
- DOI
- https://doi.org/10.14309/crj.0000000000001870
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- North American Society for Pediatric Gastroenterology, Hepatology and Nutrition